![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 39, 27717-27725, September 24, 1999
From the The three-dimensional structures of two HPII
variants, V169C and H392Q, have been determined at resolutions of 1.8 and 2.1 Å, respectively. The V169C variant contains a new type of
covalent bond between the sulfur atom of Cys169 and a
carbon atom on the imidazole ring of the essential His128.
This variant enzyme has only residual catalytic activity and contains
heme b. The chain of water molecules visible in the main channel may
reflect the organization of the hydrogen peroxide substrates in the
active enzyme. Two alternative mechanisms, involving either compound I
or free radical intermediates, are presented to explain the formation
of the Cys-His covalent bond. The H392Q and H392E variants exhibit 75 and 25% of native catalytic activity, respectively. The
Gln392 variant contains only heme b, whereas
the Glu392 variant contains a mixture of heme b and
cis and trans isomers of heme d, suggesting of
a role for this residue in heme conversion. Replacement of either
Gln419 and Ser414, both of which interact with
the heme, affected the cis:trans ratio of spirolactone heme
d. Implications for the heme oxidation mechanism and the His-Tyr bond
formation in HPII are considered.
Catalase (hydrogen peroxide:hydrogen peroxide oxidoreductase, EC
1.11.1.6) is an ubiquitous component of the defense system against
oxidative stress that virtually all cells growing under aerobic
conditions possess. The crystal structures of six heme-containing catalases have now been solved revealing a common highly conserved core
in all enzymes. These structures include three prokaryote enzymes,
Micrococcus luteus catalase (1), Proteus
mirabilis_PR (2), and Escherichia coli hydroperoxidase
II (HPII)1 (3, 4), and three
eukaryote enzymes, Penicillium vitale (PVC) (5, 6), catalase
A from Saccharomyces cerevisiae (7), and bovine liver
catalase (8, 9).
Catalase catalyzes the dismutation of hydrogen peroxide by one of two
reaction pathways depending on conditions. Both pathways begin with the
formation of compound I, an intermediate which holds two oxidation
equivalents (basically an oxyferryl group with the iron in the
Fe+4 state and a porphyrin cation radical) (10, 11)
(Reaction 1).
The structure of native HPII, solved and refined at 1.9-Å resolution
contains a cis-hydroxychlorin Materials--
Standard chemicals and biochemicals were obtained
from Sigma. Restriction nucleases, polynucleotide kinase, DNA ligase,
and the Klenow fragment of DNA polymerase were obtained from Life Technologies, Inc.
Strains and Plasmids--
The plasmid pAMkatE72 (15) was used as
the source for the katE gene. Phagemids pKS+ and pKS Oligonucleotide-directed Mutagenesis--
Oligonucleotides were
synthesized on a PCR-Mate synthesizer from Applied Biosystems and are
listed in Table I. The restriction nuclease fragments, that were mutagenized following the Kunkel procedure (18), sequenced and subsequently reincorporated into pAMkatE72 to generate the mutagenized katE genes, are also
listed. Sequence confirmation of all sequences was by the Sanger method (20) on double-stranded plasmid DNA generated in JM109. Subsequent expression and purification were carried out as described previously (21).
Catalase Assay and Protein Determination--
Catalase activity
was determined by the method of Rørth and Jensen (22) in a Gilson
oxygraph equipped with a Clark electrode. One unit of catalase is
defined as the amount that decomposes 1 µmol of
H2O2 in 1 min in a 60 mM
H2O2 solution at pH 7.0 at 37 °C. Protein
was estimated according to the methods outlined by Layne (23).
Matrix-assisted Laser Desorption/Ionization Mass Spectrometry
(MALDI-MS)--
250 µg of protein was boiled for 3 min in 50 mM potassium phosphate, pH 7.0, and mixed with 7 µg of
trypsin at room temperature for 1 h. The solution was boiled a
second time and treated with an additional 7 µg of trypsin for 1 h after which the solution was boiled and lyophilized. The dried sample
was dissolved in 2 ml of saturated Crystallization, Data Collection, and Structure
Determination--
Crystals of HPII variants V169C and H392Q were
obtained in the vicinity of the conditions previously described for the
wild type enzyme HPII (3). A diffraction data set for the V169C variant
was collected at station X11 in DESY. The crystal was frozen in liquid
nitrogen with 30% MPD added to the crystallization buffer. Diffraction
data were processed with DENZO and scaled with SCALEPACK (25) (Table
II). For the H392Q variant, data were
collected using a rotating anode x-ray source and graphite monochromator at 100 K in the same cryobuffer. Data were processed and
scaled using MOSFLM (26) and SCALA (27, 28), respectively (Table II).
The refined model of native HPII at 1.9-Å resolution (4) was used as
the starting model for both structures, and this model was improved by
automatic refinement alternated with manual rebuilding using programs
XPLOR (29), REFMAC (30), and O (31), respectively. The
Rfree criteria was used during all the
refinement but no reflections were omitted in the map Fourier synthesis
calculations. A distance restraint and the removal of the non-bonded
interactions between atoms participating in the new His-Cys bond were
used during the final steps of the V169C refinement. Restraints due to
the non-crystallographic symmetry were only taken into account in the
initial steps of refinement to 2.5-Å resolution. Bulk solvent
correction was included and the whole resolution was used in the
refinement. The corresponding final crystallographic agreement factors,
R and Rfree, together with other
refinement parameters are summarized in Table II. Solvent accessibility
and cavities were calculated with VOIDOO (32). For polar atoms the
atomic radii used were smaller than the van der Waals value (33). This
allows us to take into account the fact that when two atoms form a
hydrogen bond, the observed interatomic distance is smaller than the
sum of the atomic radii. Atomic coordinates and structure factors have
been deposited with Protein Data Bank with entry codes 1qf7 and
1cf9 for the H392Q and V169C variants of HPII, respectively.
Major Channel Variants of HPII--
The side chain of
Val169 is situated immediately above the essential residue
His128 where the major access channel enters the distal
heme pocket (Fig. 1A). This
valine is fully preserved among all known catalase sequences and it is
placed in the narrowest and most hydrophobic section of the channel.
Changing the equivalent residue in catalase A from S. cerevisiae to a smaller residue (V111A) resulted in an enzyme with
reduced catalatic activity but enhanced peroxidatic activity for larger
substrates (34). This was attributed to a disruption in the flow of
H2O2 in the enlarged channel and to easier
access for the larger peroxidatic substrates. The rationale behind
changing Val169 Crystal Structure of the V169C Variant of HPII--
The
three-dimensional structure of the V169C variant of HPII was determined
and refined using synchrotron data at 1.8-Å resolution. The starting
model was the structure of native HPII at 1.9-Å resolution (4), from
which the substituted residue and neighboring solvent molecules were
omitted. The final refined V169C structure, with crystallographic
agreement factors of r = 18.1% and
Rfree = 23.7%, provided a clean electron
density map which showed a number of significant differences with
respect to wild type HPII (Fig. 1, A and B). All
of these differences were clustered in the vicinity of either the
mutated residue or the heme group.
The most striking feature evident in the final electron density maps of
the V169C variant is the presence of a covalent bond between the sulfur
atom of Cys169 and the imidazole ring of His128
(Fig. 1B and Fig. 2). The
shape of the electron density and the refinement behavior strongly
suggest that, within the limitations of the resolution available, the
sulfur atom from Cys169 together with all the atoms from
the imidazole ring of His128 are in a common plane. Perfect
planarity implies that the atoms in the imidazole ring retain the
sp2 hybridization state which imposes strong
constraints on the possible chemical mechanisms that can produce the
covalent bond. The modified imidazole ring is rotated about
30o relative to its position in wild type HPII and its
orientation can be unambiguously defined by the proximity of a water
molecule within 3.1 Å of the imidazole N
The moderate increase in the heme channel volume that results from the
Val to Cys replacement can only explain in part the presence of four
extra solvent molecules in the variant enzyme (Figs. 1, B
and D, and 2). These solvent molecules form a continuous hydrogen bonded chain that extends the full-length of the channel from
the molecular surface to the distal pocket, ending with the water
molecule above the heme iron. The presence of this continuous chain of
solvent molecules reaching the active center proves that the low
activity of this mutant is not a result of steric hindrance to
substrate access. In native HPII, the solvent chain is interrupted in
the vicinity of Val-169.
The V169C variant crystal structure confirmed the presence of heme b,
rather than heme d as had already been suggested by HPLC analysis, and
also confirmed the mass spectroscopic analyses that showed the absence
of the Tyr415-His392 covalent bond found in
wild type HPII. The absence of the two covalent modifications in the
V169C variant is similar to the situation found in the structure of the
inactive or weakly active variants, H128A, H128N, and N201H (Fig.
3)
(12).2 In these structures,
Gln419 is rotated forming a hydrogen bond with the heme
propionate side chain and with a water molecule located near
Thr416. Furthermore, the main chain from residues 414 to
417 is shifted with respect to the native model, and
Ile126, on the heme distal side, exists in two
conformations likely due to the restrictions imposed by its proximity
to the propionate chain (Fig. 3).
Mass Analysis of Tryptic Peptides--
An independent confirmation
of the presence of the His128-Cys169 covalent
bond was provided by a mass analysis, using MALDI-MS, of trypsin
digests of wild type HPII and of the V169C variant. Complete digestion
of HPII by trypsin should generate a mixture of 75 peptide products,
which will be further complicated, particularly below 3000 Da, by the
presence of partial digest products. His128 and
Val169 (or Cys169) are situated on separate
tryptic peptides (Fig. 4B).
The His128-containing peptide extends from
Ile126 to Arg130 and has a predicted mass of
596 Da. The Val169-containing peptide extends from
Phe166 to Arg180, and replacement of Val with
Cys would increase the predicted mass from 1453 to 1457 Da. Covalent
linkage of the His128- and Cys169-containing
peptides through the imidazole-sulfur bond would produce a 2051-Da
peptide, assuming that 2 hydrogens were lost as part of the covalent
bond formation. The mass spectrum of a tryptic digest of wild type HPII
(Fig. 4A) confirms the absence of significant peptide peaks
in the 2000 to 2100 Da range. By comparison, the mass spectrum of a
tryptic digest of the V169C variant (Fig. 4B) shows a
prominent peak in this range with a mass of 2051, consistent with the
presence of the His128-Cys169 covalent
linkage.
Heme Proximal Side Variants of HPII--
The conversion of heme b
to heme d and of the formation of the
His392-Tyr415 covalent bond in HPII have been
linked in a concerted mechanism that requires the formation of compound
I. The proposed mechanism was supported by the observation that neither
modification is found in the catalytically inactive variants of HPII,
H128A, H128N, and N201H (13).2 In PVC, the His-Tyr bond
cannot be formed because the residue that would correspond to the
histidine is a glutamine. However, PVC does form heme d proving that
heme oxidation and His-Tyr bond formation can be unlinked and
suggesting the possibility that the two reactions may occur separately
in HPII. To test this possibility, the HPII mutant variant, H392Q, was
constructed to make HPII reflect the structure of PVC, and the H392E,
H392A, and H392D variants were constructed for comparison. All of these
variants retained activity ranging from 20 to 75% of wild type
activity (Table III). Spectroscopic and HPLC analysis revealed that
three of the variants, including the Gln, Asp, and Ala replacements,
contained only heme b consistent with a coupling of His-Tyr bond
formation and heme modification. Despite the activity of the variants,
the characteristic heme b spectra were indistinguishable from the
spectra for the inactive mutants, H128A, H128N, and N201H previously
reported (21). Surprisingly, the H392E variant was found to have a
mixture of heme b and heme d (Fig. 5)
indicating that heme conversion could occur, albeit at a slower rate.
However, the picture is complicated by the presence of large amounts of
the trans isomer of the spirolactone in the H392E variant as
compared with the predominantly cis isomer in PVC and HPII,
and by the presence of an unidentified heme peak that eluted between
the peaks of heme d and b.
Crystal Structure of H392Q--
Determination of the crystal
structure of the H392Q variant of HPII was undertaken because it
differed significantly from wild type HPII in lacking both the His-Tyr
bond and heme d despite retaining near wild type activity. The
structure, determined and refined following a similar approach to the
one described for the V169C variant, gave crystallographic agreement
factors r = 14.4% and Rfree = 21.0% for data at 2.1-Å resolution collected with a conventional
rotating anode x-ray source and a graphite monochromator. A number of
structural changes with respect to native HPII, including a few
rearrangements in the solvent structure and the presence of the heme b
group were evident in the electron density (Fig. 1C).
Changes directly related to the presence of heme b, such as the double
conformation of Ile126 on the heme distal side and the
rotation of Gln419 on the heme proximal side, are
consistent with changes already described for the V169C structure (Fig.
3). Additional changes around the mutated residue, Gln392,
included the hydrogen bonding of Gln419 with both the
propionate side chain of the heme group and a molecule of water that is
also hydrogen bonded with the amide nitrogen atom of Gln392
(Fig. 3). This water, not present in the native HPII structure, is
found in PVC and in the HPII variants, V169C and H392Q.
Gln419 has the same disposition in the structures of all
the HPII variants containing heme b regardless of whether residue 392 is Gln or His (Fig. 3).
A water molecule in PVC and in the H392Q variant of HPII occupies the
space that corresponds to the imidazole group in the native HPII
structure. This water is in direct contact with the C Involvement of Other Proximal Side Residues--
The concerted
mechanism that couples heme oxidation to His-Tyr bond formation
implicated His395 and Asp197 as playing a role
in the reaction (13). The H395A, H395Q, D197A, and D197S variants of
HPII were constructed to test this hypothesis. These four mutants all
retained near wild type levels of activity and contained both heme d
and the His-Tyr bond (Table III). The only difference from wild type
was the apparently slightly slower heme conversion rate in the case of
the H395A variant indicating that His395 and
Asp197 do not have a significant role in heme conversion or
His-Tyr bond formation.
Both Ser414 and Gln419 are located in close
proximity to the heme. Ser414 is hydrogen bonded with the
hydroxyl group on ring III of the heme d, and its
interaction with the incoming hydroxyl group might potentially
influence the oxidation reaction. Gln419 is hydrogen bonded
with the carbonyl group of the spirolactone on ring III in HPII and
with the propionate side chain in the HPII variants that contain heme
b. It seems likely that the association continues throughout the
oxidation and cyclization reaction providing the Gln residue with an
opportunity to influence the heme modification pathway. The mutant
variants S414A, Q419A, and Q419H were constructed to test these
hypotheses. The three variants retained 40% or more of wild type
activity (Table III) indicating that the residues were not critical to
the catalytic function of the enzyme. Spectral and HPLC analyses
revealed a distribution of hemes quite different from that of wild type
HPII (Fig. 5). For the two Gln419 mutant variants, there
was a larger than normal peak of the trans isomer of heme d
(~30% of the total as compared with 10% in the native HPII)
indicating that changing the Gln residue affected the direction of
lactone cyclization. Even more dramatic was the elution pattern of heme
from the S414A variant which contained more trans than
cis isomer and some heme b indicating that the Ser414 residue has important catalytic roles both in
directing the path of reaction and in facilitating the reaction.
The report of unusual covalent modifications in proteins is
becoming increasingly common as accurate information about large structures is becoming available. Examples in redox related systems include the methionine sulfone found in the active site of catalase from P. mirabilis (2), the cysteine-sulfenic acid in the
NADH peroxidase from Streptococcus faecalis (35), the
oxidized tryptophan residue in lignin peroxidase (36), the modified
cysteine in catalase HPII (37), the internal cyclization of the peptide backbone in the green fluorescent protein (38), and the His-Tyr covalent bond in catalase HPII (13). The bond between the
C Two possible mechanisms to explain the formation of the
imidazole-sulfur bond can be proposed involving either an
acid-catalyzed, nucleophile-mediated reaction (39) or a free radical
mediated reaction. The protonation of His128 may facilitate
the nucleophilic attack of the thiol group of Cys169 on the
C
Mutants That Alter the Covalent Structure of Catalase
Hydroperoxidase II from Escherichia coli*
,
,
,
, and
CID (Consejo Superior de Investigaciones
Cietifícas) Jordi Girona 18-26, 08034 Barcelona, Spain, the
§ Department of Microbiology, University of Manitoba,
Winnipeg, Manitoba R3T 2N2, Canada, and the ¶ Department of
Physics, University of Manitoba, Winnipeg,
Manitoba R3T 2N2, Canada
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Compound I is an active oxidant which can either react with a
second molecule of H2O2 to give dioxygen and
water, completing the catalatic mechanism (Reaction 2), or oxidize
another small substrate molecule, for example ethanol, completing the
peroxidatic mechanism (Reaction 3),
Under certain conditions, compound I can be reduced by a
one-electron addition resulting in the formation of compound II (a
formal Fe4+ state) which can lead to inactivation of the
enzyme. Small subunit catalases (12), utilize NADPH to prevent the
accumulation of compound II while the large subunit enzymes, HPII and
PVC, do not form compound II, which may explain why they do not require NADPH.
-spirolactone heme d and a
novel type of covalent bond joining the C
of the
essential Tyr415 and the N
of
His392 (4, 13). As part of an ongoing study of catalases,
HPII mutant variants with changes in Val169,
Asp197, His392, His395,
Ser414, and Gln419 were produced. The HPII
variant V169C, designed to investigate the effect of changes in the
major channel leading to the active site, was found to contain an
unusual covalent bond between the essential histidine
(His128) and the substituted residue (Cys169).
Variants in other positions were produced to study the mechanism of
heme oxidation and Tyr-His bond formation in HPII. In particular, a
variant of His392 was designed to change the residue to its
Gln (14) counterpart in PVC which has heme d but not the His-Tyr bond.
We report here the enzymatic characterization of 12 mutant variants of
HPII and the structure determination of two of them, V169C and H392Q,
refined at 1.8- and 2.1-Å resolution, respectively. Implications of
the biochemical and structural peculiarities found for these variant enzymes are discussed.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
from
Stratagene Cloning Systems were used for mutagenesis, sequencing, and
cloning. E. coli strains NM522 (supE thi
(lac-proAB) hsd-5 [F' proAB
lacIq lacZ
15]; Ref. 16),
JM109 (recA1 supE44 endA1 hsdR17 gyrA96 relA1 thi
(lac-proAB; Ref. 17), and CJ236 (dut-1 ung-1 thi-1 relA1/pCJ105 F'; Ref. 18) were used as hosts for the plasmids and
for generation of single-strand phage DNA using helper phage R408.
Strain UM255 (pro leu rpsL hsdM hsdR endI lacY katG2
katE12::Tn10 recA; Ref. 19) was used for
expression of the mutant katE constructs and isolation of
the mutant HPII proteins.
Oligonucleotides and katE restriction fragments used in
oligonucleotide-directed mutagenesis of katE
-cyano-4-hydroxycinnamic acid in
acetonitrile, 0.1% trifluoroacetic acid (1:2 by volume). 1 µl was
applied to the sample probe and air dried for MALDI-MS using the
Manitoba reflecting time-of-flight mass spectrometer (24). The
instrument was operated in positive-ion linear mode.
Desorption/ionization was achieved by a pulsed ultraviolet laser beam
(N2 laser,
= 337 nm). The acceleration voltage was
20 kV and the laser power density was approximately 106
W/cm2. The mass spectrum of each sample was the average of
more than 100 shots. For mass calibration, bovine insulin (5733 Da) was used.
Data collection and structural refinement statistics
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Cys in HPII was that subsequent
selective reaction of the sulfhydryl group might allow progressive
blockage of the access channel. This objective was precluded by the
finding that the purified V169C mutant had only about 0.1% of the
native HPII activity, and contained heme b as determined by HPLC and
spectral analyses (Table III). In order
to define if these dramatic and unexpected changes were a result of
steric factors or another property specific to the cysteine residue,
the V169A and V169S mutant variants were constructed. These two variant
enzymes contained heme d and exhibited about 25% of wild type
activity, similar to the change in activities of the equivalent Val
mutants in catalase A from S. cerevisiae and significantly
higher than the activity of the V169C variant. No
o-dianisidine peroxidatic activity was detected. From this, it was concluded that the Cys residue was a determining factor in the
reduced catalatic activity and in the lack of conversion of heme b to
heme d. How a residue located outside the heme pocket could have such
important catalytic effects remained puzzling and structure
determination of the V169C variant was considered appropriate.

View larger version (69K):
[in a new window]
Fig. 1.
Stereo views of the heme distal side pocket
and of the final part of the major channel in wild type HPII
(A), the V169C variant (B), and the
H392Q variant (C). The corresponding electron
densities are shown for the three cases. In the V169C variant
structure, a chain of well defined solvent molecules reach the distal
pocket as compared with the native and H392Q structures where solvent
molecules are not visible in the final part of the main channel. D,
stereo view, in the same orientation as the previous figures, of the
solvent accessibility of native HPII (solid blue) and V169C
(yellow frame). The subtle enlargement of the final part of
the channel in the V169C structure is enough to allow the entrance of
solvent molecules in that part of the channel in the mutant. The
solvent molecules found in the mutant are indicated as red
balls and the heme is shown for reference.
Characterization of the HPII mutant variants
atom and by
the bifurcated hydrogen bond formed by N
with both
O
from Ser167 and main chain carbonyl oxygen
from Thr168 (Fig. 2). This leaves the C
of
the imidazole ring situated just 1.84 Å from the cysteine sulfur atom,
a distance consistent with a covalent bond. The rigidity introduced by
the new Cys-His covalent bond that would likely raise the
pKa of the imidazole ring together with the altered
imidazole-heme stacking, should both contribute to the diminished
catalytic activity of the V169C variant.

View larger version (57K):
[in a new window]
Fig. 2.
Stereo view (rotated by about
180o with respect to Fig. 1) of the environment
of the covalent bond formed between the S atom of the mutated residue
(Cys169) and the carbon atom
C
from the imidazole ring of the
essential histidine (His128). Also the
2Fo
Fc electron density map is
shown, calculated after simulated annealing with His128,
Cys169, and the five waters filling the channel excluded.
The electron density suggests that the bonded sulfur and all the atoms
in the imidazole ring are situated in a common plane (see the text)
with a dihedral angle
(Cys
169-Ser169-Cys
128-Asn
128)
of 76o. The relative orientation of the imidazole ring,
defined by both the presence of a water molecule hydrogen bonded to the
N
and the bifurcated hydrogen bond formed between the
N
with O
from Ser167 and
O
from Thr168 departs about 30o
from the orientation found in the active enzyme. The geometry of this
Cys-His bond imposes strong restraints on the possible mechanisms of
formation.

View larger version (24K):
[in a new window]
Fig. 3.
Stereo views of the heme proximal side in
native HPII (A), PVC (B), the variant
V169C (C), and the variant H392Q
(D). The native HPII structure contains a
modified heme d and also presents a covalent bond between the
C
of Tyr415 and N
of
His392. The structure of the HPII variant H392Q contains an
unmodified heme b cofactor but retains a high catalatic activity. The
structure of PVC also contains a modified heme d group, although the
configuration in the vicinity of the essential tyrosine is very close
to the one determined for the HPII variant H392Q. Both in PVC and in H392Q, a water molecule fills the space
occupied by the imidazole ring of His392 in HPII. The
green trace in B, C, and D indicates
the location of the equivalent atoms in native HPII.

View larger version (21K):
[in a new window]
Fig. 4.
Mass analysis of the mixtures of peptide
fragments generated by trypsin digestion of HPII (A)
and the V169C variant (B). Only the 1800 to 2300 Da mass range is shown. The two fragments joined by the Cys-His
covalent bond and their calculated masses are shown in the
inset to B.

View larger version (21K):
[in a new window]
Fig. 5.
Reversed-phase HPLC chromatograms for the
heme isolated from HPII catalase (A) and the mutant
variants H392Q (B), H392E (C), Q419H
(D), and S414A (E). The peaks of heme d are
indicated by d and the peak of heme b is indicated by
b. The faster eluting peak of heme d is the cis
isomer and the slower eluting peak is the trans
isomer.
atom of the essential tyrosine (Tyr350 in PVC and
Tyr415 in HPII) suggesting a strong polarization of this
region. Otherwise, the solvent organization on the heme proximal side
in the H392Q variant is very similar to that of active HPII. The
solvent structure on the distal side of the heme is similar to wild
type HPII with no solvent molecules being present in the final part of
the major channel which indicates that neither the presence of heme b
nor the double conformation of Ile126 affect the solvent
organization in the major channel. The presence of only one solvent
molecule in the pocket immediately above the heme (Fig. 3C;
corresponding to W0 in native HPII) rather than two found in native
HPII could indicate that accessibility to the iron is somewhat
diminished in the H392Q structure. Whether this is due to
Ile126, to the heme b, or to the water being a weaker
ligand in the heme b environment is not yet clear.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
of the imidazole ring of His128 and the
sulfur of Cys169 in the V169C mutant variant of HPII is yet
another example of an unexpected and unusual covalent bond located in
the core of a protein. The presence of this linkage, with essentially
full occupancy, is well supported by both the electron density of the crystal structure and the sizes of fragments in the tryptic digest maps. The strong peptide peak in the mass spectrum indicates that the
bond is relatively stable and does not break down readily under trypsin
digest or MALDI-MS conditions.
of the imidazole ring (Fig.
6A). This would yield an
intermediate with the C
converted to
sp3 hybridization which could return to
sp2 hybridization through release of a hydride
ion to the oxyferryl group of compound I. The same mechanism could be
revised slightly such that the protonation of His128 at the
initial stage of compound I formation triggers the nucleophilic attack
by the thiol group (Fig. 6B).

View larger version (12K):
[in a new window]
Fig. 6.
Possible mechanisms for the formation of the
covalent bond found in the V169C variant of HPII between the mutated
residue Cys169 and the essential histidine
His128. Scheme A shows the proposed
nucleophilic mechanism based on the acid catalyzed nucleophilic
addition of the thiol group of Cys169 onto the imidazole
ring of His128. Scheme B shows an alternate
mechanism where protonation of His128, in the initial step
of compound I formation, triggers the nucleophilic attack of the thiol
group of Cys169 on the imidazole ring. Scheme C
depicts the proposed free radical mechanism based on the oxidation of
the thiol group of Cys169 to yield a thiyl radical which
can attack the imidazolic system.
Free radical addition of thiols to double bonds can be initiated by
peroxides (40) providing several pathways for a free radical mechanism.
The initial oxidation of the thiol group of Cys169 by
H2O2 would yield a reactive thiyl radical which
could then attack the C
of His128 as shown
in Fig. 6C. The participation of compound I as the oxidant of the thiol seems less likely given the 7.9 Å distance between the
Cys-SH and the heme iron.
The absence of heme modification and of the His-Tyr covalent bond in the V169C mutant variant, both of which require compound I formation, suggest that compound I is not formed in this HPII variant, apparently invalidating mechanisms such as those in Fig. 6, A and B. The solution to this dilemma lies in the likelihood that the formation of the His-Cys bond is a more rapid reaction than either the heme modification or the His-Tyr bond formation. Reaction with the sulfur may occur in the first few catalytic rounds before any other modification occurs resulting in rapid modification of the essential His128 imidazole ring. Once His128 is modified, compound I cannot be formed and further modification cannot take place. A second explanation involves the replacement of compound I as primary oxidant by hydrogen peroxide as a hydride acceptor in the nucleophilic mechanism or the free radical mechanism (Fig. 6C).
The concerted mechanism that combines heme oxidation with His-Tyr bond formation in HPII seems to be corroborated by the properties of the H392Q variant of HPII. This variant was surprising in retaining a high percentage of native activity despite the presence of heme b and the absence of the His-Tyr bond which demonstrated that neither heme d nor the His-Tyr bond is essential for the activity of HPII. The H392E variant which contains some heme d but no His-Tyr bond appears to contradict the assumption of a linkage between the heme modification and His-Tyr bond formation and confirms that an alternate mechanism is possible in HPII. However, the slower rate of heme conversion and the abnormal heme profile as compared with native HPII suggest that the alternate mechanism may be different from that normally operating in the native enzyme. By the same criteria, the mechanism in the H392E variant would appear to be different from that operating in PVC.
Both Gln419 and Ser414 have roles in
controlling the heme oxidation reaction as is evident in the fact that
changing either residue causes changes in the cis:trans
ratio of the spirolactone. The most dramatic change results from
removal of Ser414, consistent with it being hydrogen bonded
with the OH on ring III. Interaction with the Ser414 side
chain must stabilize the hydroxyl group on the proximal side of the
heme, presumably limiting isomerization to the more stable
trans isomer and ensuring formation of the cis
isomer. The S414A variant contains the His-Tyr bond even when retaining some of the unmodified heme b group. All the inactive HPII variants analyzed lacked the two covalent modifications (13), which suggest that
compound I formation is required for these modifications to take place.
| |
ACKNOWLEDGEMENT |
|---|
Thanks are due to Dr. M. Ortiz-Lombardia for help on diffraction data collection as a result of the 98 Advanced Training Course on Expression, Purification and Crystallization of Proteins at DESY-EMBL in Hamburg.
| |
FOOTNOTES |
|---|
* This work was supported by Direccion General de Investigacion Ciencia Y Technologia Grant PB95-0218 and the European Union through the Human Capital Mobility Project to Large Installations Project (contract CHGE-CT93-0040) (in Barcelona), Natural Sciences and Engineering Research Council of Canada Grant RGP9600 (in Winnipeg), and NATO Collaborative Research Grant SA-5-2-05 (to P. C. L. and I. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (codes 1qf7 and 1cf for H392Q and V169C variants of HPII, respectively) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
To whom correspondence should be addressed: Dept. of
Microbiology, University of Manitoba, Winnipeg, MB R3T 2N2 Canada.
Tel.: 204-474-8334; Fax: 204-474-7603; E-mail:
peter_loewen{at}umanitoba.ca.
2 J. Bravo, J. Switala, P. C. Loewen, and I. Fita, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HPII, hydroperoxidase II; PVC, P. vitale catalase A; MALDI-MS, matrix-assisted laser desorption-mass spectrometry; HPLC, high performance liquid chromatograph.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Murshudov, G. N., Melik-Adamyan, W. R., Grebenko, A. I., Barynin, V. V., Vagin, A. A., Vainshtein, B. K., Dauter, Z., and Wilson, K. S. (1992) FEBS Lett. 312, 127-131[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Gouet, P., Jouve, H. M., and Dideberg, O. (1995) J. Mol. Biol. 249, 933-954[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Bravo, J., Verdaguer, N., Tormo, J., Betzel, C., Switala, J., Loewen, P. C., and Fita, I. (1995) Structure 3, 491-502[Medline] [Order article via Infotrieve] |
| 4. | Bravo, J., Maté, M. J., Schneider, T., Switala, J., Wilson, K., Fita, I., and Loewen, P. C. (1999) Proteins 34, 155-166[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Vainshtein, B. K., Melik-Adamyan, W. R., Barynin, V. V., Vagin, A. A., Grebenko, A. I., Borisov, V. V., Bartels, K. S., Fita, I., and Rossmann, M. G. (1986) J. Mol. Biol. 188, 49-61[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Melik-Adamyan, W. R., Barynin, V. V., Vagin, A. A., Borisov, V. V., Vainshtein, B. K., Fita, I., Murthy, M. R. N., and Rossmann, M. G. (1986) J. Mol. Biol. 188, 63-72[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Maté, M. J., Zamocky, M., Nykyri, L. M., Herzog, C., Alzari, P. M., Betzel, C., Koller, F., and Fita, I. (1999) J. Mol. Biol. 286, 135-149[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Murthy, M. R. N., Reid, T. J., III, Sicignano, A., Tanaka, N., and Rossmann, M. G. (1981) J. Mol. Biol. 152, 465-499[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Fita, I., Silva, A. M., Murthy, M. R. N., and Rossmann, M. G. (1986) Acta Crystallogr. Sect. B 42, 497-515[CrossRef] |
| 10. |
Dolphin, D.,
Forman, A.,
Borg, D. C.,
Fajer, J.,
and Felton, R. H.
(1971)
Proc. Natl. Acad. Sci. U. S. A.
68,
614-618 |
| 11. | Ivancich, A., Jouve, H. M., Sartor, B., and Gaillard, J. (1997) Biochemistry 36, 9356-9364[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Bravo, J., Fita, I., Gouet, P., Jouve, H. M., Melik-Adamyan, W., and Murshudov, G. N. (1997) in Oxidative Stress and the Molecular Biology of Antioxidant Defenses (Scandalios, J. G., ed) , pp. 407-445, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 13. | Bravo, J., Fita, I., Ferrer, J. C., Ens, W., Hillar, A., Switala, J., and Loewen, P. C. (1996) Protein Sci. 6, 1016-1023[Abstract] |
| 14. | Kozlov, E. A., Levitina, T. L., Bobrovskaia, M. T., Gudkova, L. V., Latyshko, N. V., and Radomskii, N. F. (1998) Bioorg. Khim. 24, 163-170[Medline] [Order article via Infotrieve] |
| 15. |
von Ossowski, I.,
Mulvey, M. R.,
Leco, P. A.,
Borys, A.,
and Loewen, P. C.
(1991)
J. Bacteriol.
173,
514-520 |
| 16. |
Mead, D. A.,
Skorupa, E. S.,
and Kemper, B.
(1985)
Nucleic Acids Res.
13,
1103-1118 |
| 17. | Yanisch-Perron, C., Vietra, J., and Messing, J. (1985) Gene (Amst.) 33, 103-119[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Methods Enzymol. 154, 367-382[Medline] [Order article via Infotrieve] |
| 19. | Mulvey, M. R., Sorby, P. A., Triggs-Raine, B. L., and Loewen, P. C. (1988) Gene (Amst.) 73, 337-345[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Sanger, F. S.,
Nicklen, S.,
and Coulsen, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467 |
| 21. | Loewen, P. C., Switala, J., von Ossowski, I., Hillar, A., Christie, A., Tattrie, B., and Nicholls, P. (1993) Biochemistry 32, 10159-10164[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Rørth, M., and Jensen, P. K. (1967) Biochim. Biophys. Acta 139, 171-173[Medline] [Order article via Infotrieve] |
| 23. | Layne, E. (1957) Methods Enzymol. 3, 447-454 |
| 24. | Ens, W., Spicer, V., Standing, K. G., and Zhou, J. (1993) Org. Mass Spectrom. 28, 1430-1434[CrossRef] |
| 25. | Otwinowski, Z., and Minor, W. (1996) Methods Enzymol. 276, 307-326 |
| 26. | Leslie, A. G. W. (1991) in Crystallographic Computing V (Moras, D. , Podjanry, A. D. , and Thierry, J. C., eds) , pp. 27-38, Oxford University Press, Oxford, UK |
| 27. | Evans, P. R. (1997) Joint CCP4 and ESF-EACBM Newsletters 33, 22-24 |
| 28. | Collaborative Computational Project, Number 4. (1994) Acta Crystallogr. Sect. D 50, 760-763[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Brünger, A. T. (1992) XPLOR Manual, Version 3 , Yale University, New Haven, CT |
| 30. | Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Acta Crystallogr. Sect. D 53, 240-255[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Jones, T. A., Zon, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. A 47, 110-119 |
| 32. | Kleywegt, G. J., and Jones, T. A. (1994) Acta Crystallogr. Sect. D 50, 178-185[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Williams, M. A., Goodfellow, J. M., and Thornton, J. M. (1994) Protein Sci. 3, 1224-1235[Abstract] |
| 34. | Zamocky, M., Herzog, C., Nykyri, L. M., and Koller, F. (1995) FEBS Lett. 367, 241-245[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Stehle, T., Ahmed, S. A., Claiborne, A., and Schulz, G. E. (1991) J. Mol. Biol. 221, 1325-1344[Medline] [Order article via Infotrieve] |
| 36. | Blodig, W., Doyle, W. A., Smith, A. T., Winterhalter, K., Choinowski, T., and Piontek, K. (1998) Biochemistry 37, 8832-8838[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Sevinc, S., Ens, W., and Loewen, P. C. (1995) Eur. J. Biochem. 230, 127-132[Medline] [Order article via Infotrieve] |
| 38. | Ormo, M., Cubitt, A. B., Kallio, K., Gross, L. A., Trien, R. Y., and Remington, S. J. (1996) Science 273, 1392-1395[Abstract] |
| 39. | Peach, M. E. (1974) in The Chemistry of the Thiol Group, Part II (Patai, S., ed) , pp. 721-784, J. Wiley & Sons, London |
| 40. | Griesbaum, K. (1970) Angew. Chem. Int. Ed. 9, 273-287[CrossRef] |
This article has been cited by other articles:
![]() |
C. Piau, J. Jehan, R. Leclercq, and C. Daurel Catalase-Negative Staphylococcus aureus Strain with Point Mutations in the katA Gene J. Clin. Microbiol., June 1, 2008; 46(6): 2060 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jakopitsch, E. Droghetti, F. Schmuckenschlager, P. G. Furtmuller, G. Smulevich, and C. Obinger Role of the Main Access Channel of Catalase-Peroxidase in Catalysis J. Biol. Chem., December 23, 2005; 280(51): 42411 - 42422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ghiladi, G. M. Knudsen, K. F. Medzihradszky, and P. R. O. de Montellano The Met-Tyr-Trp Cross-link in Mycobacterium tuberculosis Catalase-peroxidase (KatG): AUTOCATALYTIC FORMATION AND EFFECT ON ENZYME CATALYSIS AND SPECTROSCOPIC PROPERTIES J. Biol. Chem., June 17, 2005; 280(24): 22651 - 22663. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chelikani, X. Carpena, I. Fita, and P. C. Loewen An Electrical Potential in the Access Channel of Catalases Enhances Catalysis J. Biol. Chem., August 15, 2003; 278(33): 31290 - 31296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milani, P.-Y. Savard, H. Ouellet, P. Ascenzi, M. Guertin, and M. Bolognesi A TyrCD1/TrpG8 hydrogen bond network and a TyrB10TyrCD1 covalent link shape the heme distal site of Mycobacterium tuberculosis hemoglobin O PNAS, May 13, 2003; 100(10): 5766 - 5771. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||